RenovoRx RNXT
NASDAQ RNXT
$1.76 -0.23 (-11.53%)
As of: Sep 10, 2026 · 3:08 PM EDT

RenovoRx (RNXT) Invested Capital (2020)

RenovoRx's (RNXT) quarterly Invested Capital came in at -$12.0 million in Q4 2020.

Analysis

RenovoRx (RNXT) Invested Capital (2020) Analysis & Trends

RenovoRx has disclosed Invested Capital across 1 years of filings, most recently posting -$12.0 million for Q4 2020.

  • In Q4 2020, Invested Capital changed N/A year-over-year to -$12.0 million; the TTM figure through Dec 2020 stood at -$12.0 million (changed N/A YoY), while the FY2020 annual figure was -$12.0 million, changed N/A from the prior year.
  • Invested Capital came in at -$12.0 million for Q4 2020 at RenovoRx.
  • In the past five years, Invested Capital ranged from a high of -$12.0 million in Q4 2020 to a low of -$12.0 million in Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 180.55 Bn 174.95 Bn 7.27 Bn 84.37 Bn
2 Intuitive Surgical 128.01 Bn 122.80 Bn 1.96 Bn -
3 Medtronic 117.17 Bn 108.35 Bn 6.34 Bn 79.00 Bn
4 Stryker 104.15 Bn 100.67 Bn 4.50 Bn 38.93 Bn
5 Boston Scientific 63.37 Bn 62.83 Bn 3.85 Bn 37.80 Bn
6 Edwards Lifesciences 49.75 Bn 45.50 Bn 1.35 Bn 11.32 Bn
7 Alcon 33.01 Bn 31.55 Bn 1.68 Bn 25.74 Bn
8 Dexcom 32.16 Bn 30.22 Bn 830.00 Mn -
9 Steris 20.74 Bn 20.25 Bn 684.20 Mn 9.36 Bn
10 RenovoRx 83.24 Mn 83.24 Mn 766,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -12.01 Mn